# Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

> **NCT03186755** · PHASE4 · UNKNOWN · sponsor: **Michael Marchand, MD** · enrollment: 42 (estimated)

## Conditions studied

- Conjunctivitis, Allergic
- Conjunctivitis, Vernal

## Interventions

- **DRUG:** Hyaluronic acid 0.05% & Ectoine 2.0%
- **DRUG:** Olopatadine hydrochloride ophthalmic solution 0.1%

## Key facts

- **NCT ID:** NCT03186755
- **Lead sponsor:** Michael Marchand, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-11
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2022-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03186755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03186755, "Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03186755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*